- Transcript 'Boleac.CG.SB_v3.S225...' >
- Transcript 'Moocci.CG.ELv1_2.S34...' >
- Transcript 'Cisavi.CG.ENS81.R2.3...'
Transcript Model
Transcript Id
Cisavi.CG.ENS81.R2.305036-327173.06278.t
Possible name(s)
EPHA4; EPHB1; EPHB2
Gene model
Location
R2 [305,592 / 325,643]
Amino acid sequence
Length: 937
>Cisavi.CG.ENS81.R2.305036-327173.06278.p
ILYDTKSATSDLNWALHPQTYGWEELSGRDVNGNTIRYHQVCNVDEEEQDNWVRSPFIDA
RSAQRVYMDIEFSVMKCEECRETFALYYYQSSADIATSTFPPWRENPYTKIDTLAAGERF
DSSTVGAEGINRKTLVISPLSRRGFYVAAQDQGACMSLMSLKLYYYYCPETTHNLAYFSR
TLSGGEVASLVAQSGKCVSNSVYSNNEVPKYRCNSYGEWRVPTGSCHCRAGYQPNEELTT
CQGCSVGSYKPENGNIQCQACPAHSLTRSVGADHCSCVDGYYRADGDSIHQACSRTPSQP
KNITFTLNKTSVSMNWMEPVITGERSDIFYSVACQECESGYKNCRSCPSTIQPSPSNLHH
LTTTNAQLNNLKPYSHYSIKVGLQYILLLMCPPQIQRLRLVESGQTYFVVAWMSTPTPTT
HLLEYQVRVFQNGHKIKDINVRMNCVTFSTNATVSGLTKGSKYIAKVRVRNGMGYGKFSN
DLYVATSSAKEQATAGLNPAVIGGVMGVIAIVIIVIIVLFVKRRQANKKKRQDQETRGKH
KSSQEQVSQWRTYVDYRDPHNGVKEIATELDQTKIKIECVIGRGRWCLTVCRGKLISGKT
SIPVAVKRLKEGASLIDHTNFLREACTMAQFDHPNIIQLKGVVTKSIPAMIITEFMENGS
LDKFLQGKVNELTASRLLEMLRGIASGMNYLSSIKYIHRDLAARNILVSSDLVCKVSDFG
LSRTLENDPQATYTTQGGKIALRWTAPECIRFRQFTSASDVWSYGIVMWEVMSYGEKPYW
DMSNEVVTEVLEDGYRLPAPENCPVSIHNLMLKCWSYEAKRRPHPIEIIRTLDQFIKQPN
LLLDTKSHDASAPLLNPDSPTSLNEVSTLDEWLDMVKLGKYRRSFHTNGINDLESLVHIS
ESELDRLGITSPAHRTRLQGGISTLRQHLGEFPNTRQ
Nucleotide sequence
Length: 2,811
>Cisavi.CG.ENS81.R2.305036-327173.06278.t
ATATTGTACGACACCAAATCGGCTACAAGTGACTTGAATTGGGCGCTCCACCCACAAACT
TATGGGTGGGAAGAACTAAGCGGACGTGACGTCAACGGAAACACGATAAGATACCACCAA
GTGTGCAATGTGGACGAAGAGGAACAAGATAACTGGGTTCGGTCGCCATTTATTGACGCA
AGATCGGCTCAACGTGTTTACATGGACATTGAGTTTTCCGTAATGAAATGCGAGGAATGT
CGTGAAACATTCGCGCTGTATTACTACCAGTCGTCCGCTGACATCGCTACCAGCACTTTT
CCACCGTGGAGGGAAAACCCCTATACCAAGATCGACACGCTAGCTGCAGGGGAACGATTT
GACTCGAGCACTGTAGGTGCTGAGGGGATAAACAGGAAGACTTTGGTGATCAGTCCGCTA
TCAAGGCGAGGGTTCTACGTGGCAGCCCAGGACCAAGGAGCATGCATGTCGTTGATGAGT
CTCAAGTTGTATTATTATTACTGCCCTGAGACCACGCACAACCTCGCTTATTTCTCGAGG
ACCTTATCAGGGGGTGAAGTCGCGTCGCTCGTTGCGCAATCCGGCAAATGCGTCTCCAAC
TCCGTATACTCTAACAACGAAGTTCCGAAATACCGCTGCAACAGCTACGGTGAATGGAGA
GTACCGACTGGTTCGTGCCACTGTCGAGCTGGCTACCAACCGAACGAAGAACTAACTACG
TGCCAAGGTTGCAGTGTGGGGAGTTACAAACCGGAGAATGGGAACATACAATGCCAAGCC
TGCCCCGCACATAGCTTGACTAGGAGCGTAGGGGCAGATCATTGTTCATGTGTGGATGGT
TACTATCGAGCTGATGGAGACTCAATACACCAAGCTTGTTCTAGGACACCATCTCAGCCA
AAGAATATCACCTTTACATTGAACAAAACTTCCGTTTCAATGAACTGGATGGAACCGGTT
ATAACTGGTGAAAGATCGGACATATTTTACAGTGTGGCATGCCAGGAATGCGAGAGTGGG
TACAAGAACTGCCGATCATGTCCCTCCACCATCCAACCCTCCCCTTCCAACCTCCACCAC
CTCACAACCACCAACGCCCAACTCAATAACCTCAAACCATACTCTCATTATTCAATCAAG
GTAGGTTTGCAATATATTTTATTGTTAATGTGTCCACCCCAAATACAACGATTAAGGCTT
GTAGAAAGTGGACAAACATATTTTGTGGTGGCCTGGATGTCAACCCCCACGCCTACAACC
CACTTGCTCGAATATCAAGTCAGAGTTTTCCAAAACGGACACAAGATTAAAGACATAAAC
GTGAGAATGAATTGTGTAACATTCTCCACTAATGCTACAGTGAGTGGGTTAACCAAGGGA
AGCAAATACATCGCGAAGGTCAGAGTGAGAAATGGAATGGGATACGGAAAATTCAGCAAT
GACCTTTACGTGGCCACTTCTTCGGCCAAAGAACAAGCGACTGCCGGTTTAAACCCCGCA
GTGATCGGGGGTGTGATGGGGGTGATCGCGATAGTTATCATCGTGATCATAGTGTTGTTC
GTCAAGCGAAGACAAGCCAACAAGAAGAAGAGACAGGATCAAGAAACTCGCGGAAAACAC
AAATCTTCTCAAGAGCAAGTTTCTCAATGGCGCACCTACGTCGACTACCGAGACCCTCAT
AATGGGGTGAAGGAAATCGCAACCGAACTCGATCAAACTAAGATCAAGATCGAATGCGTC
ATTGGGAGAGGTAGGTGGTGTTTAACAGTGTGCCGAGGAAAGTTGATATCGGGCAAGACT
TCCATCCCGGTTGCCGTGAAACGCTTGAAGGAAGGAGCAAGTTTGATCGATCACACTAAC
TTCTTGAGGGAAGCTTGCACAATGGCTCAGTTTGATCATCCTAACATCATCCAACTTAAA
GGGGTCGTCACTAAAAGTATTCCAGCCATGATAATCACCGAGTTTATGGAGAATGGATCA
TTGGACAAGTTTCTACAGGGCAAAGTGAATGAACTGACTGCCTCGAGGTTGCTTGAGATG
TTACGAGGTATAGCGAGTGGGATGAACTATCTCTCCTCCATCAAATACATCCACAGAGAT
CTTGCTGCTCGCAACATCCTCGTCAGTTCTGACCTCGTTTGCAAAGTTTCAGACTTCGGA
CTTTCGAGGACCCTGGAAAATGACCCCCAAGCTACCTATACTACACAGGGCGGGAAGATT
GCTCTGCGCTGGACGGCACCCGAGTGCATACGCTTCCGACAATTCACGTCAGCGAGTGAC
GTATGGAGTTACGGCATCGTCATGTGGGAAGTGATGTCATACGGGGAGAAGCCATACTGG
GATATGAGCAATGAGGTGGTCACTGAGGTCTTGGAGGATGGATATCGCCTCCCAGCCCCT
GAGAACTGCCCAGTATCCATCCACAATCTGATGCTGAAGTGTTGGAGCTATGAAGCGAAG
AGGAGGCCTCATCCCATTGAGATCATCCGGACTTTGGATCAGTTCATCAAACAACCTAAC
CTCCTCCTGGACACCAAGTCACATGACGCAAGCGCCCCACTACTCAACCCAGACAGCCCC
ACCAGTTTAAACGAGGTGTCCACACTTGATGAATGGCTGGACATGGTGAAGCTTGGAAAA
TATCGTCGAAGTTTCCACACGAATGGAATCAACGACCTTGAAAGTCTGGTCCACATTAGT
GAAAGTGAGTTAGATCGACTTGGCATCACCTCCCCCGCCCACCGCACTCGACTTCAGGGA
GGCATCAGCACGTTGAGGCAGCATTTGGGGGAATTCCCCAACACGAGACAA
| PIRSF |
Tyr_kinase_ephrin_rcpt (IPR016257) - T[1-385] 9.8E-119 - T[389-936] 5.6E-184 |
| ProSiteProfiles |
Ephrin_rcpt_lig-bd_dom (IPR001090) - T[1-173] 54.576 |
| SMART |
Ephrin_rcpt_lig-bd_dom (IPR001090) - T[1-168] 4.2E-68 |
| Gene3D |
Galactose-bd-like_sf (IPR008979) - T[1-168] 1.5E-59 |
| Pfam |
Ephrin_rcpt_lig-bd_dom (IPR001090) - T[1-168] 3.1E-57 |
| SUPERFAMILY |
Galactose-bd-like_sf (IPR008979) - T[2-166] 1.19E-54 |
| SUPERFAMILY |
Growth_fac_rcpt_cys_sf (IPR009030) - T[205-296] 1.96E-6 - T[334-353] 1.96E-6 |
| SMART |
Tyr-kin_ephrin_A/B_rcpt-like (IPR011641) - T[231-275] 1.9E-7 |
| Pfam |
Tyr-kin_ephrin_A/B_rcpt-like (IPR011641) - T[231-273] 1.8E-8 |
| SUPERFAMILY |
FN3_sf (IPR036116) - T[296-487] 1.24E-18 |
| Gene3D |
Ig-like_fold (IPR013783) - T[297-382] 2.6E-15 - T[390-497] 5.6E-11 |
| SMART |
FN3_dom (IPR003961) - T[297-389] 1.3 - T[392-476] 4.2E-6 |
| CDD |
FN3_dom (IPR003961) - T[297-381] 3.17996E-5 - T[392-486] 3.56707E-9 |
| Pfam |
FN3_dom (IPR003961) - T[298-381] 3.6E-8 - T[394-479] 5.8E-8 |
| ProSiteProfiles |
FN3_dom (IPR003961) - T[394-489] 13.878 |
| Pfam |
Eph_TM (IPR027936) - T[502-571] 1.8E-13 |
| SUPERFAMILY |
Kinase-like_dom_sf (IPR011009) - T[573-843] 3.55E-72 |
| SMART |
Tyr_kinase_cat_dom (IPR020635) - T[575-832] 7.5E-117 |
| ProSiteProfiles |
Prot_kinase_dom (IPR000719) - T[575-836] 34.45 |
| Pfam |
Ser-Thr/Tyr_kinase_cat_dom (IPR001245) - T[576-831] 1.1E-87 |
| PRINTS |
Ser-Thr/Tyr_kinase_cat_dom (IPR001245) - T[653-666] 9.6E-31 - T[690-708] 9.6E-31 - T[740-750] 9.6E-31 - T[759-781] 9.6E-31 - T[803-825] 9.6E-31 |
| ProSitePatterns |
Tyr_kinase_AS (IPR008266) - T[696-708] . |
| SUPERFAMILY |
SAM/pointed_sf (IPR013761) - T[857-927] 5.89E-16 |
| SMART |
SAM (IPR001660) - T[861-928] 1.6E-12 |
| ProSiteProfiles |
SAM (IPR001660) - T[864-928] 15.208 |
| Pfam |
SAM (IPR001660) - T[864-926] 6.3E-12 |
| Protein Name | Identity | Bit Score | e-value |
|---|---|---|---|
| EPHB1_HUMAN | 40.205 % | 720 | 0 |
| EPHA4_HUMAN | 41.572 % | 744 | 0 |
| EPHB2_HUMAN | 40.989 % | 756 | 0 |